Clene Inc. is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases. It serves markets related to amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.